11-74457316-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_005472.5(KCNE3):​c.248G>A​(p.Arg83His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00477 in 1,614,148 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R83C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0038 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 31 hom. )

Consequence

KCNE3
NM_005472.5 missense

Scores

2
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:12

Conservation

PhyloP100: 2.00

Publications

34 publications found
Variant links:
Genes affected
KCNE3 (HGNC:6243): (potassium voltage-gated channel subfamily E regulatory subunit 3) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, isk-related subfamily. This member is a type I membrane protein, and a beta subunit that assembles with a potassium channel alpha-subunit to modulate the gating kinetics and enhance stability of the multimeric complex. This gene is prominently expressed in the kidney. A missense mutation in this gene is associated with hypokalemic periodic paralysis. [provided by RefSeq, Jul 2008]
KCNE3 Gene-Disease associations (from GenCC):
  • Brugada syndrome 6
    Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Brugada syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012397826).
BP6
Variant 11-74457316-C-T is Benign according to our data. Variant chr11-74457316-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 5541.
BS2
High AC in GnomAd4 at 580 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005472.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE3
NM_005472.5
MANE Select
c.248G>Ap.Arg83His
missense
Exon 3 of 3NP_005463.1Q9Y6H6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNE3
ENST00000310128.9
TSL:1 MANE Select
c.248G>Ap.Arg83His
missense
Exon 3 of 3ENSP00000310557.4Q9Y6H6
KCNE3
ENST00000525550.1
TSL:1
c.248G>Ap.Arg83His
missense
Exon 2 of 2ENSP00000433633.1Q9Y6H6
KCNE3
ENST00000875764.1
c.248G>Ap.Arg83His
missense
Exon 4 of 4ENSP00000545823.1

Frequencies

GnomAD3 genomes
AF:
0.00381
AC:
580
AN:
152194
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00484
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00616
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00300
AC:
753
AN:
251278
AF XY:
0.00286
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00243
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00282
Gnomad NFE exome
AF:
0.00491
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00487
AC:
7112
AN:
1461836
Hom.:
31
Cov.:
30
AF XY:
0.00470
AC XY:
3421
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00116
AC:
39
AN:
33480
American (AMR)
AF:
0.00266
AC:
119
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000344
AC:
9
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86254
European-Finnish (FIN)
AF:
0.00296
AC:
158
AN:
53398
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00584
AC:
6492
AN:
1111988
Other (OTH)
AF:
0.00452
AC:
273
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
391
781
1172
1562
1953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00381
AC:
580
AN:
152312
Hom.:
2
Cov.:
32
AF XY:
0.00349
AC XY:
260
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00135
AC:
56
AN:
41564
American (AMR)
AF:
0.00483
AC:
74
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00616
AC:
419
AN:
68022
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00431
Hom.:
5
Bravo
AF:
0.00362
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00676
AC:
58
ExAC
AF:
0.00296
AC:
359
EpiCase
AF:
0.00485
EpiControl
AF:
0.00409

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
3
not provided (5)
-
1
3
Brugada syndrome 6 (4)
-
2
2
not specified (4)
-
-
1
Cardiomyopathy (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities (1)
-
-
1
Periodic paralysis (1)
-
1
-
Syncope;C0042510:Ventricular fibrillation (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.030
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.88
D
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
0.052
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
2.0
PrimateAI
Uncertain
0.57
T
PROVEAN
Pathogenic
-4.4
D
REVEL
Uncertain
0.58
Sift
Benign
0.044
D
Sift4G
Benign
0.077
T
Polyphen
0.0030
B
Vest4
0.47
MVP
0.93
MPC
0.15
ClinPred
0.027
T
GERP RS
3.4
Varity_R
0.49
gMVP
0.88
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17215437; hg19: chr11-74168361; COSMIC: COSV107382359; COSMIC: COSV107382359; API